from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2699c/-

LFCtreatmentdescriptionclass of inhibitor

3.148

Amikacinug/mL Amikacintranslation

1.948

Cap5-10ug/mL Capreomycintranslation

1.935

Rox10-50 ug/mL Roxithromycintranslation

1.390

SM2-5 ug/mL Streptomycintranslation

3.651

Tet5-10 ug/mL Tetracyclinetranslation

0.186

Rif0.2-5ug/mL Rifampicintranscription

1.431

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.337

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.172

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.200

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.102

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.778

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.936

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.468

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.761

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.548

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.345

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.113

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.623

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.936

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.472

KCN5-20 ug/mL Potassium cyaniderespiration

-1.058

NaN30.2-2 mM Sodium aziderespiration

1.947

Nigericin50 uM Nigericinrespiration

-0.125

TRC10-150 ug/mL Triclosanrespiration

1.061

TRZ10-25 ug/mL Thioridazinerespiration

-0.199

Valinomycin0.5-10 uM Valinomycinrespiration

-0.097

ZnSO42 mM ZnSO4respiration

1.730

menadione6-10 ug/mL Menadionerespiration

-0.362

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.339

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.212

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.137

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.115

NRP_1Non-replicating persistence stage 1dosRassociated

0.123

Amp0.2mg/mL AmpicillincellWall

0.015

Cephalexin20-100 ug/mL CephalexincellWall

0.765

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.020

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.200

EMB10-20 ug/mL EthambutolcellWall

0.561

Eta12-40 ug/mL EthionamidecellWall

0.974

INH0.2-0.4 ug/mL IsoniazidcellWall

0.059

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.410

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.413

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.694

BZA0.12 mg/mL BenzamidearomaticAmides

-0.777

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.148

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.119

H2O24 mM hydrogen peroxideDNAdamaging

-0.349

Levo10 ug/mL LevofloxacinDNAdamaging

0.270

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.110

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.366

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.315

UVUV-irradiationDNAdamaging

3.548

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.306

Antimycin12.5-50 ug/mL Antimycin A?

-0.092

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.815

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.503

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.987

PA8240.2-2 ug/mL PA-824?

-0.911

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.566

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.456

Verapamil50 uM Verapamil?

-0.211

mercaptoethanol2 mM 2-Mercaptoethanol?

0.170

methoxatin10-20 ug/mL Methoxatin?